STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Monthly information on share capital and company voting rights

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags

Cellectis (CLLS) has released its monthly share capital and voting rights information as of July 31, 2024, in compliance with French financial market regulations. The report indicates that the total number of shares in the capital is 100,093,635, while the total number of voting rights stands at 88,029,164. This information is important for investors to understand the company's ownership structure and potential voting power distribution.

The press release provides contact details for media and investor relations, including Pascalyne Wilson (Director of Communications) and Arthur Stril (Interim Chief Financial Officer). This transparency in reporting and accessibility to company representatives demonstrates Cellectis' commitment to maintaining open communication channels with stakeholders and complying with regulatory requirements.

Loading...
Loading translation...

Positive

  • Transparent reporting of share capital and voting rights information
  • Compliance with French financial market regulations

Negative

  • None.

News Market Reaction 1 Alert

+1.47% News Effect

On the day this news was published, CLLS gained 1.47%, reflecting a mild positive market reaction.

Data tracked by StockTitan Argus on the day of publication.

(Article 223-16 of General Regulation of the French financial markets authority)

PARIS, Aug. 05, 2024 (GLOBE NEWSWIRE) --

Listing market: Euronext Growth

ISIN code: FR0010425595

DateTotal number of shares
in the capital
Total number of voting
rights
07/31/2024100,093,63588,029,164


For further information on Cellectis, please contact:
     

Media contact:       

Pascalyne Wilson, Director, Communications, +33 (0)7 76 99 14 33, media@cellectis.com

Patricia Sosa Navarro, Chief of Staff to the CEO, +33 (0)7 76 77 46 93

Investor Relations contacts:       

Arthur Stril, Interim Chief Financial Officer, +1 (347) 809 5980, investors@cellectis.com 

 

Attachment


FAQ

What is the total number of shares in Cellectis (CLLS) capital as of July 31, 2024?

As of July 31, 2024, the total number of shares in Cellectis (CLLS) capital is 100,093,635.

How many voting rights does Cellectis (CLLS) have as of July 31, 2024?

Cellectis (CLLS) has 88,029,164 total voting rights as of July 31, 2024.

On which market are Cellectis (CLLS) shares listed?

Cellectis (CLLS) shares are listed on the Euronext Growth market.

What is the ISIN code for Cellectis (CLLS) stock?

The ISIN code for Cellectis (CLLS) stock is FR0010425595.
Cellectis

NASDAQ:CLLS

CLLS Rankings

CLLS Latest News

CLLS Latest SEC Filings

CLLS Stock Data

523.70M
72.33M
3.85%
18.77%
0.21%
Biotechnology
Healthcare
Link
France
Paris